Envestnet Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $31.2M | Buy |
95,796
+23,749
| +33% | +$7.74M | 0.01% | 982 |
|
|
2025
Q1 | $19.5M | Buy |
72,047
+6,033
| +9% | +$1.63M | 0.01% | 1208 |
|
|
2024
Q4 | $15.5M | Buy |
66,014
+34,647
| +110% | +$8.15M | 0.01% | 1347 |
|
|
2024
Q3 | $8.63M | Buy |
31,367
+6,227
| +25% | +$1.71M | ﹤0.01% | 1737 |
|
|
2024
Q2 | $6.11M | Sell |
25,140
-2,295
| -8% | -$558K | ﹤0.01% | 1888 |
|
|
2024
Q1 | $4.1M | Buy |
27,435
+156
| +0.6% | +$23.3K | ﹤0.01% | 2117 |
|
|
2023
Q4 | $5.22M | Buy |
27,279
+2,709
| +11% | +$519K | ﹤0.01% | 1871 |
|
|
2023
Q3 | $4.35M | Buy |
24,570
+5,727
| +30% | +$1.01M | ﹤0.01% | 1894 |
|
|
2023
Q2 | $3.58M | Buy |
18,843
+3,477
| +23% | +$660K | ﹤0.01% | 1908 |
|
|
2023
Q1 | $3.08M | Buy |
15,366
+1,280
| +9% | +$256K | ﹤0.01% | 1925 |
|
|
2022
Q4 | $3.35M | Sell |
14,086
-3,000
| -18% | -$713K | ﹤0.01% | 1833 |
|
|
2022
Q3 | $3.42M | Buy |
17,086
+2,972
| +21% | +$595K | ﹤0.01% | 1738 |
|
|
2022
Q2 | $2.06M | Sell |
14,114
-17,306
| -55% | -$2.52M | ﹤0.01% | 2089 |
|
|
2022
Q1 | $5.13M | Sell |
31,420
-2,893
| -8% | -$472K | ﹤0.01% | 1588 |
|
|
2021
Q4 | $5.82M | Buy |
34,313
+2,828
| +9% | +$480K | ﹤0.01% | 1510 |
|
|
2021
Q3 | $5.94M | Buy |
31,485
+1,480
| +5% | +$279K | ﹤0.01% | 1420 |
|
|
2021
Q2 | $5.09M | Buy |
30,005
+3,378
| +13% | +$573K | ﹤0.01% | 1510 |
|
|
2021
Q1 | $3.76M | Buy |
26,627
+12,998
| +95% | +$1.83M | ﹤0.01% | 1581 |
|
|
2020
Q4 | $1.77M | Sell |
13,629
-24,953
| -65% | -$3.24M | ﹤0.01% | 1831 |
|
|
2020
Q3 | $5.62M | Sell |
38,582
-1,758
| -4% | -$256K | 0.01% | 1106 |
|
|
2020
Q2 | $5.98M | Buy |
40,340
+31,940
| +380% | +$4.73M | 0.01% | 1038 |
|
|
2020
Q1 | $914K | Buy |
+8,400
| New | +$914K | ﹤0.01% | 1869 |
|